TreeWAS – Variant ID: rs6876032

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Z97.5 Presence of (intra-uterine) contraceptive device	0.012	0.988	0.000
I49.5 Sick sinus syndrome	0.012	0.988	0.000
I49 Other cardiac arrhythmias	0.012	0.988	0.000
I49.8 Other specified cardiac arrhythmias	0.011	0.989	0.000
Z97.8 Presence of other specified devices	0.011	0.989	0.000
Z97 Presence of other devices	0.011	0.989	0.000
I49.0 Ventricular fibrillation and flutter	0.011	0.989	0.000
J92.9 Pleural plaque without asbestos	0.011	0.989	0.000
I49.1 Atrial premature depolarisation	0.010	0.990	0.000
Z97.0 Presence of artificial eye	0.010	0.990	0.000
I49.4 Other and unspecified premature depolarisation	0.010	0.990	0.000
H90.5 Sensorineural hearing loss, unspecified	0.000	0.990	0.010
U80.1 Methicillin resistant agent	0.000	0.990	0.010
K50.9 Crohn's disease, unspecified	0.000	0.991	0.009
M46.96 Inflammatory spondylopathy, unspecified (Lumbar region)	0.000	0.991	0.009
Z97.3 Presence of spectacles and contact lenses	0.009	0.991	0.000
I49.2 Junctional premature depolarisation	0.008	0.991	0.000
I49.3 Ventricular premature depolarisation	0.008	0.991	0.000
M46.9 Inflammatory spondylopathy, unspecified	0.000	0.992	0.008
Z97.1 Presence of artificial limb (complete)(partial)	0.008	0.992	0.000
M46.90 Inflammatory spondylopathy, unspecified (Multiple sites in spine)	0.000	0.992	0.008
M46.99 Inflammatory spondylopathy, unspecified (Site unspecified)	0.000	0.992	0.008
J92 Pleural plaque	0.007	0.993	0.000
U80 Agent resistant to penicillin and related antibiotics	0.000	0.993	0.007
Z97.2 Presence of dental prosthetic device (complete)(partial)	0.007	0.993	0.000
K50.0 Crohn's disease of small intestine	0.000	0.993	0.007
K50 Crohn's disease [regional enteritis]	0.000	0.993	0.007
Z97.4 Presence of external hearing-aid	0.007	0.993	0.000
U80.0 Penicillin resistant agent	0.000	0.993	0.007
M46.97 Inflammatory spondylopathy, unspecified (Lumbosacral region)	0.000	0.993	0.007
M46.92 Inflammatory spondylopathy, unspecified (Cervical region)	0.000	0.994	0.006
M46.95 Inflammatory spondylopathy, unspecified (Thoracolumbar region)	0.000	0.994	0.006
M46.94 Inflammatory spondylopathy, unspecified (Thoracic region)	0.000	0.994	0.006
M46.93 Inflammatory spondylopathy, unspecified (Cervicothoracic region)	0.000	0.994	0.006
M46.91 Inflammatory spondylopathy, unspecified (Occipito-atlanto-axial region)	0.000	0.994	0.006
J92.0 Pleural plaque with presence of asbestos	0.006	0.994	0.000
H90 Conductive and sensorineural hearing loss	0.000	0.994	0.006
M46.98 Inflammatory spondylopathy, unspecified (Sacral and sacrococcygeal region)	0.000	0.994	0.006
I49.9 Cardiac arrhythmia, unspecified	0.006	0.994	0.000
H72.9 Perforation of tympanic membrane, unspecified	0.000	0.994	0.006
K50.1 Crohn's disease of large intestine	0.000	0.994	0.006
H90-H95 Other disorders of ear	0.000	0.995	0.005
Z85.7 Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues	0.005	0.995	0.000
H93 Other disorders of ear, not elsewhere classified	0.000	0.995	0.005
J90 Pleural effusion, not elsewhere classified	0.005	0.995	0.000
O20.9 Haemorrhage in early pregnancy, unspecified	0.000	0.995	0.005
H91 Other hearing loss	0.000	0.995	0.005
E21.3 Hyperparathyroidism, unspecified	0.005	0.995	0.000
E28.2 Polycystic ovarian syndrome	0.005	0.995	0.000
H90.4 Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side	0.000	0.995	0.005
H90.0 Conductive hearing loss, bilateral	0.000	0.995	0.005
H90.3 Sensorineural hearing loss, bilateral	0.000	0.995	0.005
H91.9 Hearing loss, unspecified	0.000	0.995	0.005
H93.1 Tinnitus	0.000	0.995	0.005
H90.7 Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side	0.000	0.995	0.004
J98.4 Other disorders of lung	0.005	0.995	0.000
H90.1 Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side	0.000	0.996	0.004
C85.1 B-cell lymphoma, unspecified	0.004	0.996	0.000
J90-J94 Other diseases of pleura	0.004	0.996	0.000
H72 Perforation of tympanic membrane	0.000	0.996	0.004
H93.9 Disorder of ear, unspecified	0.000	0.996	0.004
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.004	0.996	0.000
H66.3 Other chronic suppurative otitis media	0.000	0.996	0.004
E28 Ovarian dysfunction	0.004	0.996	0.000
H95 Postprocedural disorders of ear and mastoid process, not elsewhere classified	0.000	0.996	0.004
H94 Other disorders of ear in diseases classified elsewhere	0.000	0.996	0.004
H91.8 Other specified hearing loss	0.000	0.996	0.004
H90.8 Mixed conductive and sensorineural hearing loss, unspecified	0.000	0.996	0.004
K50.8 Other Crohn's disease	0.000	0.996	0.004
I50.9 Heart failure, unspecified	0.004	0.996	0.000
H93.2 Other abnormal auditory perceptions	0.000	0.996	0.004
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.000	0.996	0.004
H93.3 Disorders of acoustic nerve	0.000	0.996	0.004
H91.3 Deaf mutism, not elsewhere classified	0.000	0.996	0.004
H93.0 Degenerative and vascular disorders of ear	0.000	0.996	0.004
H72.1 Attic perforation of tympanic membrane	0.000	0.996	0.004
H91.2 Sudden idiopathic hearing loss	0.000	0.996	0.004
U80.8 Agent resistant to other penicillin-related antibiotic	0.000	0.996	0.004
H93.8 Other specified disorders of ear	0.000	0.996	0.004
E34 Other endocrine disorders	0.004	0.996	0.000
Z33 Pregnant state, incidental	0.004	0.996	0.000
E20-E35 Disorders of other endocrine glands	0.004	0.996	0.000
E34.9 Endocrine disorder, unspecified	0.004	0.996	0.000
H66 Suppurative and unspecified otitis media	0.000	0.996	0.004
H65-H75 Diseases of middle ear and mastoid	0.000	0.996	0.004
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.004	0.996	0.000
C67.5 Bladder neck	0.004	0.996	0.000
H90.6 Mixed conductive and sensorineural hearing loss, bilateral	0.000	0.996	0.003
H91.0 Ototoxic hearing loss	0.000	0.996	0.003
E23 Hypofunction and other disorders of pituitary gland	0.004	0.996	0.000
H95.0 Recurrent cholesteatoma of postmastoidectomy cavity	0.000	0.996	0.003
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.004	0.996	0.000
Z30.5 Surveillance of (intra-uterine) contraceptive device	0.003	0.997	0.000
Chapter VIII Diseases of the ear and mastoid process	0.000	0.997	0.003
H80.9 Otosclerosis, unspecified	0.000	0.997	0.003
H90.2 Conductive hearing loss, unspecified	0.000	0.997	0.003
L28.0 Lichen simplex chronicus	0.000	0.997	0.003
E21.5 Disorder of parathyroid gland, unspecified	0.003	0.997	0.000
E23.0 Hypopituitarism	0.003	0.997	0.000
H66.4 Suppurative otitis media, unspecified	0.000	0.997	0.003
E34.8 Other specified endocrine disorders	0.003	0.997	0.000
H95.9 Postprocedural disorder of ear and mastoid process, unspecified	0.000	0.997	0.003
C81 Hodgkin's disease	0.003	0.997	0.000
H69 Other disorders of Eustachian tube	0.000	0.997	0.003
C81.9 Hodgkin's disease, unspecified	0.003	0.997	0.000
E21.2 Other hyperparathyroidism	0.003	0.997	0.000
H72.2 Other marginal perforations of tympanic membrane	0.000	0.997	0.003
M48.02 Spinal stenosis (Cervical region)	0.003	0.997	0.000
E23.6 Other disorders of pituitary gland	0.003	0.997	0.000
U81 Agent resistant to vancomycin and related antibiotics	0.000	0.997	0.003
E21.4 Other specified disorders of parathyroid gland	0.003	0.997	0.000
Z30.1 Insertion of (intra-uterine) contraceptive device	0.003	0.997	0.000
H71 Cholesteatoma of middle ear	0.000	0.997	0.003
E28.9 Ovarian dysfunction, unspecified	0.003	0.997	0.000
E28.8 Other ovarian dysfunction	0.003	0.997	0.000
E28.1 Androgen excess	0.003	0.997	0.000
E28.0 Oestrogen excess	0.003	0.997	0.000
E25 Adrenogenital disorders	0.003	0.997	0.000
H91.1 Presbycusis	0.000	0.997	0.003
H94.8 Other specified disorders of ear in diseases classified elsewhere	0.000	0.997	0.003
H94.0 Acoustic neuritis in infectious and parasitic diseases classified elsewhere	0.000	0.997	0.003
H69.8 Other specified disorders of Eustachian tube	0.000	0.997	0.003
J93 Pneumothorax	0.003	0.997	0.000
E34.3 Short stature, not elsewhere classified	0.003	0.997	0.000
H70 Mastoiditis and related conditions	0.000	0.997	0.003
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.003	0.997	0.000
U50 Level of care administered to neonates	0.000	0.997	0.003
U07 Emergency use of U07	0.000	0.997	0.003
U06 Emergency use of U06	0.000	0.997	0.003
U04 Severe acute respiratory syndrome [SARS]	0.000	0.997	0.003
U52 First in a series of a regular day/night admissions	0.000	0.997	0.003
E23.7 Disorder of pituitary gland, unspecified	0.003	0.997	0.000
E22 Hyperfunction of pituitary gland	0.003	0.997	0.000
H80 Otosclerosis	0.000	0.997	0.003
Z30 Contraceptive management	0.003	0.997	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.003	0.997	0.000
C67 Malignant neoplasm of bladder	0.003	0.997	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.003	0.997	0.000
E32 Diseases of thymus	0.003	0.997	0.000
E21.0 Primary hyperparathyroidism	0.003	0.997	0.000
E34.5 Androgen resistance syndrome	0.003	0.997	0.000
E34.4 Constitutional tall stature	0.003	0.997	0.000
E34.2 Ectopic hormone secretion, not elsewhere classified	0.003	0.997	0.000
E34.1 Other hypersecretion of intestinal hormones	0.003	0.997	0.000
E35 Disorders of endocrine glands in diseases classified elsewhere	0.003	0.997	0.000
E30 Disorders of puberty, not elsewhere classified	0.003	0.997	0.000
C67.4 Posterior wall of bladder	0.003	0.997	0.000
H95.8 Other postprocedural disorders of ear and mastoid process	0.000	0.997	0.003
C83 Diffuse non-Hodgkin's lymphoma	0.003	0.997	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.003	0.997	0.000
H72.0 Central perforation of tympanic membrane	0.000	0.997	0.003
E26 Hyperaldosteronism	0.003	0.997	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.003	0.997	0.000
H66.2 Chronic atticoantral suppurative otitis media	0.000	0.997	0.003
H70.9 Mastoiditis, unspecified	0.000	0.997	0.003
J93.8 Other pneumothorax	0.003	0.997	0.000
Z30.0 General counselling and advice on contraception	0.003	0.997	0.000
H80-H83 Diseases of inner ear	0.000	0.997	0.003
C81.2 Mixed cellularity	0.003	0.997	0.000
C67.2 Lateral wall of bladder	0.003	0.997	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.003	0.997	0.000
H75 Other disorders of middle ear and mastoid in diseases classified elsewhere	0.000	0.997	0.003
H67 Otitis media in diseases classified elsewhere	0.000	0.997	0.003
U51 Admission status on psychiatric patients	0.000	0.997	0.003
C90.0 Multiple myeloma	0.003	0.997	0.000
E29 Testicular dysfunction	0.003	0.997	0.000
E20 Hypoparathyroidism	0.003	0.997	0.000
J94 Other pleural conditions	0.003	0.997	0.000
G99.2 Myelopathy in diseases classified elsewhere	0.003	0.997	0.000
H95.1 Other disorders following mastoidectomy	0.000	0.997	0.003
E23.3 Hypothalamic dysfunction, not elsewhere classified	0.003	0.997	0.000
E28.3 Primary ovarian failure	0.003	0.997	0.000
M34.9 Systemic sclerosis, unspecified	0.000	0.997	0.003
E31 Polyglandular dysfunction	0.003	0.997	0.000
E23.1 Drug-induced hypopituitarism	0.003	0.997	0.000
E34.0 Carcinoid syndrome	0.003	0.997	0.000
H66.0 Acute suppurative otitis media	0.000	0.997	0.003
U81.8 Agent resistant to other vancomycin-related antibiotic	0.000	0.997	0.003
H68 Eustachian salpingitis and obstruction	0.000	0.997	0.003
C85.0 Lymphosarcoma	0.003	0.997	0.000
C81.7 Other Hodgkin's disease	0.003	0.997	0.000
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency	0.003	0.997	0.000
C83.1 Small cleaved cell (diffuse)	0.003	0.997	0.000
Z30.8 Other contraceptive management	0.003	0.997	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.003	0.997	0.000
C67.1 Dome of bladder	0.003	0.997	0.000
H66.1 Chronic tubotympanic suppurative otitis media	0.000	0.997	0.003
Y45.1 Salicylates	0.000	0.997	0.003
Z39.0 Care and examination immediately after delivery	0.003	0.997	0.000
H92 Otalgia and effusion of ear	0.000	0.997	0.003
M46 Other inflammatory spondylopathies	0.000	0.997	0.003
C88 Malignant immunoproliferative diseases	0.003	0.997	0.000
C67.6 Ureteric orifice	0.003	0.997	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.002	0.997	0.000
C81.3 Lymphocytic depletion	0.002	0.997	0.000
H69.0 Patulous Eustachian tube	0.000	0.997	0.002
H80.0 Otosclerosis involving oval window, nonobliterative	0.000	0.997	0.003
M34.8 Other forms of systemic sclerosis	0.000	0.997	0.003
C86 Other specified types of T/NK-cell lymphoma	0.003	0.997	0.000
C81.1 Nodular sclerosis	0.002	0.997	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.003	0.997	0.000
E32.9 Disease of thymus, unspecified	0.002	0.997	0.000
H81.2 Vestibular neuronitis	0.000	0.997	0.003
J93.0 Spontaneous tension pneumothorax	0.002	0.997	0.000
Z29.0 Isolation	0.003	0.997	0.000
C95 Leukaemia of unspecified cell type	0.002	0.997	0.000
C67.0 Trigone of bladder	0.003	0.997	0.000
E25.9 Adrenogenital disorder, unspecified	0.002	0.997	0.000
E25.8 Other adrenogenital disorders	0.002	0.997	0.000
Z30.4 Surveillance of contraceptive drugs	0.002	0.997	0.000
C83.5 Lymphoblastic (diffuse)	0.002	0.997	0.000
E22.1 Hyperprolactinaemia	0.002	0.997	0.000
H70.1 Chronic mastoiditis	0.000	0.997	0.002
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.003	0.997	0.000
E22.9 Hyperfunction of pituitary gland, unspecified	0.002	0.997	0.000
E26.9 Hyperaldosteronism, unspecified	0.002	0.997	0.000
C93 Monocytic leukaemia	0.002	0.997	0.000
C83.2 Mixed small and large cell (diffuse)	0.002	0.997	0.000
C83.0 Small cell (diffuse)	0.002	0.997	0.000
H70.2 Petrositis	0.000	0.997	0.002
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.002	0.997	0.000
C81.0 Lymphocytic predominance	0.002	0.997	0.000
G04.9 Encephalitis, myelitis and encephalomyelitis, unspecified	0.003	0.997	0.000
U04.9 Severe acute respiratory syndrome [SARS], unspecified	0.000	0.997	0.002
U06.9 Emergency use of U06.9	0.000	0.997	0.002
U06.8 Emergency use of U06.8	0.000	0.997	0.002
U06.7 Emergency use of U06.7	0.000	0.997	0.002
U06.6 Emergency use of U06.6	0.000	0.997	0.002
U06.5 Emergency use of U06.5	0.000	0.997	0.002
U06.4 Emergency use of U06.4	0.000	0.997	0.002
U06.3 Emergency use of U06.3	0.000	0.997	0.002
U06.2 Emergency use of U06.2	0.000	0.997	0.002
U06.1 Emergency use of U06.1	0.000	0.997	0.002
U06.0 Emergency use of U06.0	0.000	0.997	0.002
U07.9 Emergency use of U07.9	0.000	0.997	0.002
U07.8 Emergency use of U07.8	0.000	0.997	0.002
U07.7 Emergency use of U07.7	0.000	0.997	0.002
U07.6 Emergency use of U07.6	0.000	0.997	0.002
U07.5 Emergency use of U07.5	0.000	0.997	0.002
U07.4 Emergency use of U07.4	0.000	0.997	0.002
U07.3 Emergency use of U07.3	0.000	0.997	0.002
U07.2 Emergency use of U07.2	0.000	0.997	0.002
U07.1 Emergency use of U07.1	0.000	0.997	0.002
U07.0 Emergency use of U07.0	0.000	0.997	0.002
U50.9 Inquest Adjourned Death	0.000	0.997	0.002
U50.3 Level of care administered to neonates (Maximal Intensive Care)	0.000	0.997	0.002
U50.2 Level of care administered to neonates (High Dependancy Intensive Care)	0.000	0.997	0.002
U50.1 Level of care administered to neonates (Special Care)	0.000	0.997	0.002
U50.0 Level of care administered to neonates (Normal Care)	0.000	0.997	0.002
C82.0 Small cleaved cell, follicular	0.002	0.997	0.000
C90.1 Plasma cell leukaemia	0.002	0.997	0.000
E22.8 Other hyperfunction of pituitary gland	0.002	0.997	0.000
H70.0 Acute mastoiditis	0.000	0.997	0.002
H80.2 Cochlear otosclerosis	0.000	0.997	0.002
H80.1 Otosclerosis involving oval window, obliterative	0.000	0.997	0.002
Z29.1 Prophylactic immunotherapy	0.002	0.997	0.000
C67.7 Urachus	0.002	0.997	0.000
C82.2 Large cell, follicular	0.002	0.997	0.000
E22.0 Acromegaly and pituitary gigantism	0.002	0.997	0.000
T43.2 Other and unspecified antidepressants	0.000	0.997	0.002
T45.0 Antiallergic and antiemetic drugs	0.000	0.997	0.002
U81.0 Vancomycin resistant agent	0.000	0.997	0.002
C82.6 Cutaneous follicle centre lymphoma	0.002	0.998	0.000
C82.5 Diffuse follicle centre lymphoma	0.002	0.998	0.000
E32.1 Abscess of thymus	0.002	0.998	0.000
E32.0 Persistent hyperplasia of thymus	0.002	0.998	0.000
C67.8 Overlapping lesion of bladder	0.002	0.998	0.000
C82.4 Follicular lymphoma grade IIIb	0.002	0.998	0.000
J94.9 Pleural condition, unspecified	0.002	0.998	0.000
U51.2 Previously admitted to a psychiatric hospital of another provider	0.000	0.998	0.002
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone	0.002	0.998	0.000
E30.9 Disorder of puberty, unspecified	0.002	0.998	0.000
E30.8 Other disorders of puberty	0.002	0.998	0.000
E30.1 Precocious puberty	0.002	0.998	0.000
E30.0 Delayed puberty	0.002	0.998	0.000
E35.8 Disorders of other endocrine glands in diseases classified elsewhere	0.002	0.998	0.000
E35.1 Disorders of adrenal glands in diseases classified elsewhere	0.002	0.998	0.000
E35.0 Disorders of thyroid gland in diseases classified elsewhere	0.002	0.998	0.000
H69.9 Eustachian tube disorder, unspecified	0.000	0.998	0.002
C92 Myeloid leukaemia	0.002	0.998	0.000
H73 Other disorders of tympanic membrane	0.000	0.998	0.002
C83.6 Undifferentiated (diffuse)	0.002	0.998	0.000
C83.4 Immunoblastic (diffuse)	0.002	0.998	0.000
E29.9 Testicular dysfunction, unspecified	0.002	0.998	0.000
Z30.3 Menstrual extraction	0.002	0.998	0.000
C94 Other leukaemias of specified cell type	0.002	0.998	0.000
E24 Cushing's syndrome	0.002	0.998	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.002	0.998	0.000
E26.8 Other hyperaldosteronism	0.002	0.998	0.000
E26.1 Secondary hyperaldosteronism	0.002	0.998	0.000
E32.8 Other diseases of thymus	0.002	0.998	0.000
H72.8 Other perforations of tympanic membrane	0.000	0.998	0.002
M34.1 CR(E)ST syndrome	0.000	0.998	0.002
M34 Systemic sclerosis	0.000	0.998	0.002
Z30.9 Contraceptive management, unspecified	0.002	0.998	0.000
H82 Vertiginous syndromes in diseases classified elsewhere	0.000	0.998	0.002
C67.3 Anterior wall of bladder	0.002	0.998	0.000
E20.1 Pseudohypoparathyroidism	0.002	0.998	0.000
H67.8 Otitis media in other diseases classified elsewhere	0.000	0.998	0.002
H67.1 Otitis media in viral diseases classified elsewhere	0.000	0.998	0.002
H67.0 Otitis media in bacterial diseases classified elsewhere	0.000	0.998	0.002
H75.8 Other specified disorders of middle ear and mastoid in diseases classified elsewhere	0.000	0.998	0.002
H75.0 Mastoiditis in infectious and parasitic diseases classified elsewhere	0.000	0.998	0.002
H80.8 Other otosclerosis	0.000	0.998	0.002
J93.1 Other spontaneous pneumothorax	0.002	0.998	0.000
J94.0 Chylous effusion	0.002	0.998	0.000
S89.9 Unspecified injury of lower leg	0.002	0.998	0.000
C95.9 Leukaemia, unspecified	0.002	0.998	0.000
E20.8 Other hypoparathyroidism	0.002	0.998	0.000
E20.0 Idiopathic hypoparathyroidism	0.002	0.998	0.000
E29.8 Other testicular dysfunction	0.002	0.998	0.000
E29.0 Testicular hyperfunction	0.002	0.998	0.000
M46.0 Spinal enthesopathy	0.000	0.998	0.002
E31.9 Polyglandular dysfunction, unspecified	0.002	0.998	0.000
E31.8 Other polyglandular dysfunction	0.002	0.998	0.000
E31.1 Polyglandular hyperfunction	0.002	0.998	0.000
H68.0 Eustachian salpingitis	0.000	0.998	0.002
U51.0 Not Previously admitted to a psyciatric hospital	0.000	0.998	0.002
C83.7 Burkitt's tumour	0.002	0.998	0.000
Z30-Z39 Persons encountering health services in circumstances related to reproduction	0.002	0.998	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.002	0.998	0.000
C92.0 Acute myeloid leukaemia	0.002	0.998	0.000
H70.8 Other mastoiditis and related conditions	0.000	0.998	0.002
R49.0 Dysphonia	0.000	0.998	0.002
C82.3 Follicular lymphoma grade IIIa	0.002	0.998	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.002	0.998	0.000
Z36.9 Antenatal screening, unspecified	0.002	0.998	0.000
H81 Disorders of vestibular function	0.000	0.998	0.002
H68.1 Obstruction of Eustachian tube	0.000	0.998	0.002
J94.1 Fibrothorax	0.002	0.998	0.000
C92.4 Acute promyelocytic leukaemia	0.002	0.998	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.002	0.998	0.000
M46.8 Other specified inflammatory spondylopathies	0.000	0.998	0.002
M46.5 Other infective spondylopathies	0.000	0.998	0.002
C88.9 Malignant immunoproliferative disease, unspecified	0.002	0.998	0.000
C88.7 Other malignant immunoproliferative diseases	0.002	0.998	0.000
C88.3 Immunoproliferative small intestinal disease	0.002	0.998	0.000
C88.2 Gamma heavy chain disease	0.002	0.998	0.000
C88.1 Alpha heavy chain disease	0.002	0.998	0.000
C90.3 Solitary plasmacytoma	0.002	0.998	0.000
C90.2 Plasmacytoma, extramedullary	0.002	0.998	0.000
E20.9 Hypoparathyroidism, unspecified	0.002	0.998	0.000
E26.0 Primary hyperaldosteronism	0.002	0.998	0.000
E31.0 Autoimmune polyglandular failure	0.002	0.998	0.000
J94.8 Other specified pleural conditions	0.002	0.998	0.000
Z39 Postpartum care and examination	0.002	0.998	0.000
C95.0 Acute leukaemia of unspecified cell type	0.002	0.998	0.000
M46.1 Sacro-iliitis, not elsewhere classified	0.000	0.998	0.002
Z45.2 Adjustment and management of vascular access device	0.002	0.998	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.002	0.998	0.000
C86.4 Blastic NK-cell lymphoma	0.002	0.998	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.002	0.998	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.002	0.998	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.002	0.998	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.002	0.998	0.000
K83.1 Obstruction of bile duct	0.002	0.998	0.000
E27 Other disorders of adrenal gland	0.002	0.998	0.000
M46.2 Osteomyelitis of vertebra	0.000	0.998	0.002
Z36 Antenatal screening	0.002	0.998	0.000
C92.7 Other myeloid leukaemia	0.002	0.998	0.000
C95.7 Other leukaemia of unspecified cell type	0.002	0.998	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.002	0.998	0.000
E29.1 Testicular hypofunction	0.002	0.998	0.000
T78.4 Allergy, unspecified	0.002	0.998	0.000
Z36.0 Antenatal screening for chromosomal anomalies	0.002	0.998	0.000
Z29 Need for other prophylactic measures	0.002	0.998	0.000
M46.06 Spinal enthesopathy (Lumbar region)	0.000	0.998	0.002
C84 Peripheral and cutaneous T-cell lymphomas	0.002	0.998	0.000
C93.9 Monocytic leukaemia, unspecified	0.002	0.998	0.000
C93.7 Other monocytic leukaemia	0.002	0.998	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.002	0.998	0.000
C93.2 Subacute monocytic leukaemia	0.002	0.998	0.000
C93.1 Chronic monocytic leukaemia	0.002	0.998	0.000
C93.0 Acute monocytic leukaemia	0.002	0.998	0.000
H66.9 Otitis media, unspecified	0.000	0.998	0.002
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.998	0.002
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.002	0.998	0.000
C96.8 Histiocytic sarcoma	0.002	0.998	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.002	0.998	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.002	0.998	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.002	0.998	0.000
C96.3 True histiocytic lymphoma	0.002	0.998	0.000
C96.2 Malignant mast cell tumour	0.002	0.998	0.000
C96.1 Malignant histiocytosis	0.002	0.998	0.000
C96.0 Letterer-Siwe disease	0.002	0.998	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.998	0.002
Z13.6 Special screening examination for cardiovascular disorders	0.002	0.998	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.998	0.002
Z31.0 Tuboplasty or vasoplasty after previous sterilisation	0.002	0.998	0.000
J91 Pleural effusion in conditions classified elsewhere	0.002	0.998	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.002	0.998	0.000
M46.3 Infection of intervertebral disk (pyogenic)	0.000	0.998	0.002
U51.1 Previously admitted to a psychiatric hospital of the provider	0.000	0.998	0.002
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.002	0.998	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.002	0.998	0.000
C92.3 Myeloid sarcoma	0.002	0.998	0.000
H92.0 Otalgia	0.000	0.998	0.002
M34.0 Progressive systemic sclerosis	0.000	0.998	0.002
Z38 Liveborn infants according to place of birth	0.002	0.998	0.000
M48.09 Spinal stenosis (Site unspecified)	0.002	0.998	0.000
C94.7 Other specified leukaemias	0.002	0.998	0.000
C94.5 Acute myelofibrosis	0.002	0.998	0.000
C94.3 Mast cell leukaemia	0.002	0.998	0.000
C94.2 Acute megakaryoblastic leukaemia	0.002	0.998	0.000
C94.1 Chronic erythraemia	0.002	0.998	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.002	0.998	0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.002	0.998	0.000
E24.3 Ectopic ACTH syndrome	0.002	0.998	0.000
E24.1 Nelson's syndrome	0.002	0.998	0.000
J94.2 Haemothorax	0.002	0.998	0.000
M34.2 Systemic sclerosis induced by drugs and chemicals	0.000	0.998	0.002
M10.97 Gout, unspecified (Ankle and foot)	0.000	0.998	0.002
S22.30 Fracture of rib (closed)	0.002	0.998	0.000
C92.2 Subacute myeloid leukaemia	0.002	0.998	0.000
C94.4 Acute panmyelosis	0.002	0.998	0.000
Z31 Procreative management	0.002	0.998	0.000
M46.09 Spinal enthesopathy (Site unspecified)	0.000	0.998	0.002
M46.08 Spinal enthesopathy (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M46.07 Spinal enthesopathy (Lumbosacral region)	0.000	0.998	0.002
M46.05 Spinal enthesopathy (Thoracolumbar region)	0.000	0.998	0.002
M46.04 Spinal enthesopathy (Thoracic region)	0.000	0.998	0.002
M46.03 Spinal enthesopathy (Cervicothoracic region)	0.000	0.998	0.002
M46.02 Spinal enthesopathy (Cervical region)	0.000	0.998	0.002
M46.01 Spinal enthesopathy (Occipito-atlanto-axial region)	0.000	0.998	0.002
M46.00 Spinal enthesopathy (Multiple sites in spine)	0.000	0.998	0.002
C92.5 Acute myelomonocytic leukaemia	0.002	0.998	0.000
E23.2 Diabetes insipidus	0.002	0.998	0.000
H73.1 Chronic myringitis	0.000	0.998	0.002
H92.2 Otorrhagia	0.000	0.998	0.002
H73.9 Disorder of tympanic membrane, unspecified	0.000	0.998	0.002
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.002	0.998	0.000
H81.8 Other disorders of vestibular function	0.000	0.998	0.002
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.998	0.002
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.998	0.002
Z04.8 Examination and observation for other specified reasons	0.002	0.998	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.998	0.002
T36 Poisoning by systemic antibiotics	0.000	0.998	0.002
C92.9 Myeloid leukaemia, unspecified	0.002	0.998	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.002	0.998	0.000
E24.9 Cushing's syndrome, unspecified	0.002	0.998	0.000
E27.9 Disorder of adrenal gland, unspecified	0.002	0.998	0.000
H81.4 Vertigo of central origin	0.000	0.998	0.002
H81.3 Other peripheral vertigo	0.000	0.998	0.002
Z36.1 Antenatal screening for raised alphafetoprotein level	0.002	0.998	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.998	0.002
E24.8 Other Cushing's syndrome	0.002	0.998	0.000
E24.2 Drug-induced Cushing's syndrome	0.002	0.998	0.000
E27.2 Addisonian crisis	0.002	0.998	0.000
H73.0 Acute myringitis	0.000	0.998	0.002
L28 Lichen simplex chronicus and prurigo	0.000	0.998	0.002
E24.0 Pituitary-dependent Cushing's disease	0.002	0.998	0.000
T50.4 Drugs affecting uric acid metabolism	0.000	0.998	0.002
M46.19 Sacroiliitis, not elsewhere classified-Site unspe	0.000	0.998	0.002
M46.59 Other infective spondylopathies (Site unspecified)	0.000	0.998	0.002
M46.58 Other infective spondylopathies (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M46.57 Other infective spondylopathies (Lumbosacral region)	0.000	0.998	0.002
M46.56 Other infective spondylopathies (Lumbar region)	0.000	0.998	0.002
M46.55 Other infective spondylopathies (Thoracolumbar region)	0.000	0.998	0.002
M46.54 Other infective spondylopathies (Thoracic region)	0.000	0.998	0.002
M46.53 Other infective spondylopathies (Cervicothoracic region)	0.000	0.998	0.002
M46.52 Other infective spondylopathies (Cervical region)	0.000	0.998	0.002
M46.51 Other infective spondylopathies (Occipito-atlanto-axial region)	0.000	0.998	0.002
M46.50 Other infective spondylopathies (Multiple sites in spine)	0.000	0.998	0.002
M46.89 Other specified inflammatory spondylopathies (Site unspecified)	0.000	0.998	0.002
M46.88 Other specified inflammatory spondylopathies (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M46.87 Other specified inflammatory spondylopathies (Lumbosacral region)	0.000	0.998	0.002
M46.86 Other specified inflammatory spondylopathies (Lumbar region)	0.000	0.998	0.002
M46.85 Other specified inflammatory spondylopathies (Thoracolumbar region)	0.000	0.998	0.002
M46.84 Other specified inflammatory spondylopathies (Thoracic region)	0.000	0.998	0.002
M46.83 Other specified inflammatory spondylopathies (Cervicothoracic region)	0.000	0.998	0.002
M46.82 Other specified inflammatory spondylopathies (Cervical region)	0.000	0.998	0.002
M46.81 Other specified inflammatory spondylopathies (Occipito-atlanto-axial region)	0.000	0.998	0.002
M46.80 Other specified inflammatory spondylopathies (Multiple sites in spine)	0.000	0.998	0.002
B97.7 Papillomavirus as the cause of diseases classified to other chapters	0.000	0.998	0.002
T45.4 Iron and its compounds	0.000	0.998	0.002
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.998	0.002
M46.16 Sacroiliitis, not elsewhere classified-Lumbar	0.000	0.998	0.002
M46.15 Sacroiliitis, not elsewhere classified-Thoracolumbar	0.000	0.998	0.002
M46.14 Sacroiliitis, not elsewhere classified-Thoracic	0.000	0.998	0.002
M46.13 Sacroiliitis, not elsewhere classified-Cervicothoracic	0.000	0.998	0.002
M46.12 Sacroiliitis, not elsewhere classified-Cervical	0.000	0.998	0.002
M46.11 Sacroiliitis, not elsewhere classified-Occipit-atl-axl	0.000	0.998	0.002
M46.10 Sacroiliitis, not elsewhere classified-Mult site	0.000	0.998	0.002
H73.8 Other specified disorders of tympanic membrane	0.000	0.998	0.002
M67.8 Other specified disorders of synovium and tendon	0.000	0.998	0.002
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.998	0.002
Z31.4 Procreative investigation and testing	0.002	0.998	0.000
E27.8 Other specified disorders of adrenal gland	0.002	0.998	0.000
E27.5 Adrenomedullary hyperfunction	0.002	0.998	0.000
E27.0 Other adrenocortical overactivity	0.002	0.998	0.000
L51.1 Bullous erythema multiforme	0.000	0.998	0.002
T38.1 Thyroid hormones and substitutes	0.000	0.998	0.002
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.998	0.002
T50.1 Loop [high-ceiling] diuretics	0.000	0.998	0.002
Z36.5 Antenatal screening for isoimmunisation	0.002	0.998	0.000
Z38.0 Singleton, born in hospital	0.002	0.998	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.998	0.002
M46.18 Sacroiliitis, not elsewhere classified-Sacral/sacrococ	0.000	0.998	0.002
M46.29 Osteomyelitis of vertebra (Site unspecified)	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations